Dihydralazine

Dihydralazine

SCHEMBL149629

NNc1nnc(NN)c2ccccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 1.00
MAPT P10636 4/20 1.00
TDP1 Q9NUW8 3/20 1.00
MAOA P21397 2/20 1.00
PTGS1 P23219 2/20 1.00
ADORA3 P0DMS8 1/20 1.00
OPRM1 P35372 1/20 1.00
KCNH2 Q12809 1/20 1.00
GOT1 P17174 3/20 0.75
KDM4E B2RXH2 6/20 0.59
CYP3A4 P08684 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
CYP1A2 P05177 3/20 0.59
TP53 P04637 2/20 0.59
LMNA P02545 2/20 0.59
CYP2D6 P10635 2/20 0.59
NPC1 O15118 1/20 0.59
MPO P05164 1/20 0.59
PKM P14618 1/20 0.59
THPO P40225 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dihydralazine SCHEMBL29484435 1.00 ALDH1A1 (1.00) ALDH1A1MAPTTDP1MAOAPTGS1
Dihydralazine SCHEMBL3462832 0.95 ALDH1A1 (0.90) ALDH1A1MAPTTDP1MAOAPTGS1
SCHEMBL15721355 0.89 ALDH1A1 (0.78) ALDH1A1MAPTTDP1MAOAPTGS1
Dihydralazine SCHEMBL29794531 0.87 ALDH1A1 (0.75) ALDH1A1MAPTTDP1MAOAPTGS1
SCHEMBL19358618 0.87 MAPT (0.75) ALDH1A1MAPTTDP1MAOAPTGS1
SCHEMBL496520 0.87 GOT1 (1.00) ALDH1A1MAPTTDP1MAOAPTGS1
SCHEMBL31146711 0.87 GOT1 (1.00) ALDH1A1MAPTTDP1MAOAPTGS1
Dihydralazine SCHEMBL1374523 0.87 ALDH1A1 (0.75) ALDH1A1MAPTTDP1MAOAPTGS1
SCHEMBL7413898 0.87 ALDH1A1 (0.75) ALDH1A1MAPTTDP1MAOAPTGS1
Hydrochloric Acid SCHEMBL2646490 0.85 GOT1 (0.96) ALDH1A1MAPTTDP1MAOAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2695 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4038360-B1 AJUVANT ANTIFIBROTIC THERAPY OF A SUBPOPULATION OF PATIENTS AFTER TAVI GEORG AUGUST UNIV GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS UNIVSMEDIZIN (DE) 2025-10-29 EP claimed
US-20240424024-A1 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES ELLENNBE GMBH (DE) 2024-12-26 US claimed
EP-4422671-A1 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES Ellennbe GmbH (DE) 2024-09-04 EP claimed
EP-4422668-A1 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES Ellennbe GmbH (DE) 2024-09-04 EP claimed
WO-2024084038-A1 PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES ELLENNBE GMBH (DE) 2024-04-25 WO claimed
WO-2024072316-A1 CO-CULTURE OF HUMAN INDUCED PLURIPOTENT STEM CELL (HIPSC) − DERIVED MACROPHAGES AND HEPATOCYTES FOR GENERATION OF HIPSC-KUPFFER CELLS AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2024-04-04 WO claimed
CN-116660543-A Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof 中国人民解放军陆军军医大学第一附属医院 2023-08-29 CN claimed
WO-2023072856-A1 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES ELLENNBE GMBH (DE) 2023-05-04 WO claimed
WO-2023072870-A1 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES ELLENNBE GMBH (DE) 2023-05-04 WO claimed
WO-2023072877-A1 PHARMACEUTICAL COMPOSITION AND KIT COMPRISING AN IMMUNOMODULATORY SUBSTANCE FOR TREATING DISEASES ELLENNBE GMBH (DE) 2023-05-04 WO claimed
CN-1215322-A Method for encapsulating caplets in capsules and solid dosage forms obtainable by this method WARNER LAMBERT CO (US) 1999-04-28 CN claimed
CN-1210460-A Preparations stimulating nail growth HOECHST AG (DE) 1999-03-10 CN claimed
EP-0891180-A1 PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS WARNER-LAMBERT COMPANY (US) 1999-01-20 EP claimed
WO-1998018610-A1 EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES LENGERICH BERNHARD H VAN (US) 1998-05-07 WO claimed
CN-1170346-A Process for encapsulation of caplets in capsule and solid dasage forms obtainable by such process WARNER LAMBERT CO (US) 1998-01-14 CN claimed
EP-0695172-B1 HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF UNIV GENT (BE) 1997-12-17 EP claimed
WO-1997037629-A1 PROCESS FOR ENCAPSULATION OF CAPLETS IN A CAPSULE AND SOLID DOSAGE FORMS OBTAINABLE BY SUCH PROCESS WARNER-LAMBERT COMPANY (US) 1997-10-16 WO claimed
EP-0695172-A1 HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF RIJKSUNIVERSITEIT GENT LABORATORIUM VOOR FARMACEUTISCHE TECHNOLOGIE (BE) 1996-02-07 EP claimed
WO-1994023700-A1 HIGH RELEASE SOLID PREPARATION, PREPARATION AND USE THEREOF RIJKSUNIVERSITEIT GENT LABORATORIUM VOOR FARMACEUTISCHE TECHNOLOGIE (BE) 1994-10-27 WO claimed
US-4075335-A HYPOTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1978-02-21 US claimed